Therapeutic area data standards for autosomal dominant polycystic kidney disease: A report from the Polycystic Kidney Disease Outcomes Consortium (PKDOC)

Ronald D. Perrone, Jon Neville, Arlene B. Chapman, Berenice Y. Gitomer, Dana C. Miskulin, Vicente Torres, Frank S. Czerwiec, Eslie Dennis, Bron Kisler, Steve Kopko, Holly B. Krasa, Elizabeth Leroy, Juliana Castedo, Robert W. Schrier, Steve Broadbent

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Data standards provide a structure for consistent understanding and exchange of data and enable the integration of data across studies for integrated analysis. There is no data standard applicable to kidney disease. We describe the process for development of the first-ever Clinical Data Interchange Standards Consortium (CDISC) data standard for autosomal dominant polycystic kidney disease (ADPKD) by the Polycystic Kidney Disease Outcomes Consortium (PKDOC). Definition of common data elements and creation of ADPKD-specific data standards from case report forms used in long-term ADPKD registries, an observational cohort (Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease [CRISP] 1 and 2), and a randomized clinical trial (Halt Progression of Polycystic Kidney Disease [HALT-PKD]) are described in detail. This data standard underwent extensive review, including a global public comment period, and is now available online as the first PKD-specific data standard (www.cdisc.org/therapeutic). Submission of clinical trial data that use standard data structures and terminology will be required for new electronic submissions to the US Food and Drug Administration for all disease areas by the end of 2016. This data standard will allow for the mapping and pooling of available data into a common data set in addition to providing a foundation for future studies, data sharing, and long-term registries in ADPKD. This data set will also be used to support the regulatory qualification of total kidney volume as a prognostic biomarker for use in clinical trials. The availability of consensus data standards for ADPKD has the potential to facilitate clinical trial initiation and increase sharing and aggregation of data across observational studies and among completed clinical trials, thereby improving our understanding of disease progression and treatment.

Original languageEnglish (US)
Pages (from-to)583-590
Number of pages8
JournalAmerican Journal of Kidney Diseases
Volume66
Issue number4
DOIs
StatePublished - Oct 1 2015

Fingerprint

Autosomal Dominant Polycystic Kidney
Polycystic Kidney Diseases
Clinical Trials
Therapeutics
Information Dissemination
Registries
Kidney Diseases
United States Food and Drug Administration
Terminology
Observational Studies
Disease Progression
Meta-Analysis
Randomized Controlled Trials
Biomarkers
Kidney

Keywords

  • Autosomal dominant polycystic kidney disease (ADPKD)
  • Clinical Data Interchange Standards Consortium (CDISC)
  • consensus data standards
  • controlled terminology
  • data pooling
  • disease progression biomarker
  • Polycystic Kidney Disease Outcomes Consortium (PKDOC)
  • standard data structure
  • total kidney volume (TKV)

ASJC Scopus subject areas

  • Nephrology

Cite this

Therapeutic area data standards for autosomal dominant polycystic kidney disease : A report from the Polycystic Kidney Disease Outcomes Consortium (PKDOC). / Perrone, Ronald D.; Neville, Jon; Chapman, Arlene B.; Gitomer, Berenice Y.; Miskulin, Dana C.; Torres, Vicente; Czerwiec, Frank S.; Dennis, Eslie; Kisler, Bron; Kopko, Steve; Krasa, Holly B.; Leroy, Elizabeth; Castedo, Juliana; Schrier, Robert W.; Broadbent, Steve.

In: American Journal of Kidney Diseases, Vol. 66, No. 4, 01.10.2015, p. 583-590.

Research output: Contribution to journalArticle

Perrone, RD, Neville, J, Chapman, AB, Gitomer, BY, Miskulin, DC, Torres, V, Czerwiec, FS, Dennis, E, Kisler, B, Kopko, S, Krasa, HB, Leroy, E, Castedo, J, Schrier, RW & Broadbent, S 2015, 'Therapeutic area data standards for autosomal dominant polycystic kidney disease: A report from the Polycystic Kidney Disease Outcomes Consortium (PKDOC)', American Journal of Kidney Diseases, vol. 66, no. 4, pp. 583-590. https://doi.org/10.1053/j.ajkd.2015.04.044
Perrone, Ronald D. ; Neville, Jon ; Chapman, Arlene B. ; Gitomer, Berenice Y. ; Miskulin, Dana C. ; Torres, Vicente ; Czerwiec, Frank S. ; Dennis, Eslie ; Kisler, Bron ; Kopko, Steve ; Krasa, Holly B. ; Leroy, Elizabeth ; Castedo, Juliana ; Schrier, Robert W. ; Broadbent, Steve. / Therapeutic area data standards for autosomal dominant polycystic kidney disease : A report from the Polycystic Kidney Disease Outcomes Consortium (PKDOC). In: American Journal of Kidney Diseases. 2015 ; Vol. 66, No. 4. pp. 583-590.
@article{fbbc59c53dd14f4cbac6abfef276b4fc,
title = "Therapeutic area data standards for autosomal dominant polycystic kidney disease: A report from the Polycystic Kidney Disease Outcomes Consortium (PKDOC)",
abstract = "Data standards provide a structure for consistent understanding and exchange of data and enable the integration of data across studies for integrated analysis. There is no data standard applicable to kidney disease. We describe the process for development of the first-ever Clinical Data Interchange Standards Consortium (CDISC) data standard for autosomal dominant polycystic kidney disease (ADPKD) by the Polycystic Kidney Disease Outcomes Consortium (PKDOC). Definition of common data elements and creation of ADPKD-specific data standards from case report forms used in long-term ADPKD registries, an observational cohort (Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease [CRISP] 1 and 2), and a randomized clinical trial (Halt Progression of Polycystic Kidney Disease [HALT-PKD]) are described in detail. This data standard underwent extensive review, including a global public comment period, and is now available online as the first PKD-specific data standard (www.cdisc.org/therapeutic). Submission of clinical trial data that use standard data structures and terminology will be required for new electronic submissions to the US Food and Drug Administration for all disease areas by the end of 2016. This data standard will allow for the mapping and pooling of available data into a common data set in addition to providing a foundation for future studies, data sharing, and long-term registries in ADPKD. This data set will also be used to support the regulatory qualification of total kidney volume as a prognostic biomarker for use in clinical trials. The availability of consensus data standards for ADPKD has the potential to facilitate clinical trial initiation and increase sharing and aggregation of data across observational studies and among completed clinical trials, thereby improving our understanding of disease progression and treatment.",
keywords = "Autosomal dominant polycystic kidney disease (ADPKD), Clinical Data Interchange Standards Consortium (CDISC), consensus data standards, controlled terminology, data pooling, disease progression biomarker, Polycystic Kidney Disease Outcomes Consortium (PKDOC), standard data structure, total kidney volume (TKV)",
author = "Perrone, {Ronald D.} and Jon Neville and Chapman, {Arlene B.} and Gitomer, {Berenice Y.} and Miskulin, {Dana C.} and Vicente Torres and Czerwiec, {Frank S.} and Eslie Dennis and Bron Kisler and Steve Kopko and Krasa, {Holly B.} and Elizabeth Leroy and Juliana Castedo and Schrier, {Robert W.} and Steve Broadbent",
year = "2015",
month = "10",
day = "1",
doi = "10.1053/j.ajkd.2015.04.044",
language = "English (US)",
volume = "66",
pages = "583--590",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Therapeutic area data standards for autosomal dominant polycystic kidney disease

T2 - A report from the Polycystic Kidney Disease Outcomes Consortium (PKDOC)

AU - Perrone, Ronald D.

AU - Neville, Jon

AU - Chapman, Arlene B.

AU - Gitomer, Berenice Y.

AU - Miskulin, Dana C.

AU - Torres, Vicente

AU - Czerwiec, Frank S.

AU - Dennis, Eslie

AU - Kisler, Bron

AU - Kopko, Steve

AU - Krasa, Holly B.

AU - Leroy, Elizabeth

AU - Castedo, Juliana

AU - Schrier, Robert W.

AU - Broadbent, Steve

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Data standards provide a structure for consistent understanding and exchange of data and enable the integration of data across studies for integrated analysis. There is no data standard applicable to kidney disease. We describe the process for development of the first-ever Clinical Data Interchange Standards Consortium (CDISC) data standard for autosomal dominant polycystic kidney disease (ADPKD) by the Polycystic Kidney Disease Outcomes Consortium (PKDOC). Definition of common data elements and creation of ADPKD-specific data standards from case report forms used in long-term ADPKD registries, an observational cohort (Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease [CRISP] 1 and 2), and a randomized clinical trial (Halt Progression of Polycystic Kidney Disease [HALT-PKD]) are described in detail. This data standard underwent extensive review, including a global public comment period, and is now available online as the first PKD-specific data standard (www.cdisc.org/therapeutic). Submission of clinical trial data that use standard data structures and terminology will be required for new electronic submissions to the US Food and Drug Administration for all disease areas by the end of 2016. This data standard will allow for the mapping and pooling of available data into a common data set in addition to providing a foundation for future studies, data sharing, and long-term registries in ADPKD. This data set will also be used to support the regulatory qualification of total kidney volume as a prognostic biomarker for use in clinical trials. The availability of consensus data standards for ADPKD has the potential to facilitate clinical trial initiation and increase sharing and aggregation of data across observational studies and among completed clinical trials, thereby improving our understanding of disease progression and treatment.

AB - Data standards provide a structure for consistent understanding and exchange of data and enable the integration of data across studies for integrated analysis. There is no data standard applicable to kidney disease. We describe the process for development of the first-ever Clinical Data Interchange Standards Consortium (CDISC) data standard for autosomal dominant polycystic kidney disease (ADPKD) by the Polycystic Kidney Disease Outcomes Consortium (PKDOC). Definition of common data elements and creation of ADPKD-specific data standards from case report forms used in long-term ADPKD registries, an observational cohort (Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease [CRISP] 1 and 2), and a randomized clinical trial (Halt Progression of Polycystic Kidney Disease [HALT-PKD]) are described in detail. This data standard underwent extensive review, including a global public comment period, and is now available online as the first PKD-specific data standard (www.cdisc.org/therapeutic). Submission of clinical trial data that use standard data structures and terminology will be required for new electronic submissions to the US Food and Drug Administration for all disease areas by the end of 2016. This data standard will allow for the mapping and pooling of available data into a common data set in addition to providing a foundation for future studies, data sharing, and long-term registries in ADPKD. This data set will also be used to support the regulatory qualification of total kidney volume as a prognostic biomarker for use in clinical trials. The availability of consensus data standards for ADPKD has the potential to facilitate clinical trial initiation and increase sharing and aggregation of data across observational studies and among completed clinical trials, thereby improving our understanding of disease progression and treatment.

KW - Autosomal dominant polycystic kidney disease (ADPKD)

KW - Clinical Data Interchange Standards Consortium (CDISC)

KW - consensus data standards

KW - controlled terminology

KW - data pooling

KW - disease progression biomarker

KW - Polycystic Kidney Disease Outcomes Consortium (PKDOC)

KW - standard data structure

KW - total kidney volume (TKV)

UR - http://www.scopus.com/inward/record.url?scp=84942294959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942294959&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2015.04.044

DO - 10.1053/j.ajkd.2015.04.044

M3 - Article

C2 - 26088508

AN - SCOPUS:84942294959

VL - 66

SP - 583

EP - 590

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 4

ER -